Photos: 

Some evaluation reports are public and can be downloaded from this website, while others are restricted to MSF users and can only be accessed via Tukul. This limitation is mainly due to the sensitive nature of the operational contexts and the resulting content. However, there are internal discussions about making all evaluation reports publicly searchable. If you are an MSF association member, reports are made available on various associate platforms such as www.insideOCB.com.

Country/Region

In 2015, MSF operations and medical directors recognised antibiotic resistance (ABR) as a priority and called for the elaboration of an intersectional roadmap to tackle ABR in MSF projects. The MSF ABR Task Force was consolidated in 2017 with joint medical and operational governance.

These case study reports were produced at the request of MSF-OCBA, under the management of the Vienna Evaluation Unit. They were prepared independently by the respective authors.
09/09/2019

The objective of this lessons learnt exercise was to assess the advantages and disadvantages of the UNITAID grant governance and management model for project achievements in terms of medical (and related) outcomes, strategic decisions, the potential for collaboration between multiple MSF entities and to leverage the learnings for replication in future projects. The exercise showed that the project directly delivered a new, more effective, simpler and much cheaper treatment to patients across seven countries.

This publication was produced at the request of MSF OCG, under the management of the Vienna Evaluation Unit. It was prepared independently by Hugues Juillerat, Sharon McClenaghan and Glenn O’Neil of TRAASS International.
15/01/2019

This document describes the project Lessons identified at the end of the market entry planning phase for MSF in Finland. It summarises the successes and challenges encountered during the project, lists the learning themes arising from these successes and challenges, and includes a set of lessons derived from an analysis of these learning points. The Annex contains a proposed (brief) framework with criteria and pre-requisites for a successful Market Entry Plan in MSF based on this experience. NOTE: This is not an evaluation and therefore there is no ambition for independent judgement.

This Retrospect was facilitated by the Stockholm Evaluation Unit on behalf of the Project Team. The report has been prepared by Timothy McCann.
30/10/2017

Integration of HIV/TB services is one of the priorities for the MSF movement since 2010 and in particular for OCBA that started hand over of the so-called vertical programs in the same year. This process has finished for the total of 16 vertical HIV programs of MSF-OCBA started since 2005. Integration aims to provide access to HIV/TB care to all populations in need in locations where MSF has implemented regular projects, regardless of the HIV prevalence in places such as CAR (started in 2008), South Sudan (2011) and Niger (2014).

This publication was produced at the request of MSF OCBA, under the management of the Athens Evaluation Unit. It was prepared independently by Geraldine Brun and Heinz Henghuber (TL) and managed by the Athens Evaluation Referent Dimitra Kageropoulos.
10/11/2016

2015 saw the first large scale Meningitis C outbreak in Africa since 1979. A number of challenges and problems had been noted in the way MSF operational sections in Niger, not least in terms of intersectional collaboration. Some lessons from the 2015 response had been captured. When, at the beginning of 2016, all OCs were getting ready again to respond, it was decided to evaluate the 2016 intervention in real-time.

This publication was produced at the request of programme managers for Niger in OCB, OCBA, OCG and OCP, under the management of the Stockholm Evaluation Unit. It was prepared independently by Alyson Froud.
30/06/2016

After 10 years in Zinder, the MSF mission is preparing for a successful handover of the project to the national authorities. Most of the work has been completed, and MSF can be proud of its accomplishments in Zinder. However, MSF still needs to ‘run the last mile’ in order to close its cycle in Zinder and to leave its nutritional involvement completely to the national authorities.The current evaluation was a follow-up on the initial capitalisation report done in 2014 and was initiated to assess the future of this handover.

This publication was produced at the request of MSF OCG, under the management of the Vienna Evaluation Unit. It was prepared independently by Jonathan Novoa.
19/01/2016

After 10 years in Zinder, the MSF mission is preparing for a successful handover of the project to the national authorities. Most of the work has been completed, and MSF can be proud of its accomplishments in Zinder. However, MSF still needs to ‘run the last mile’ in order to close its cycle in Zinder and to leave its nutritional involvement completely to the national authorities.The current evaluation was a follow-up on the initial capitalisation report done in 2014 and was initiated to assess the future of this handover.

This publication was produced at the request of MSF OCG, under the management of the Vienna Evaluation Unit. It was prepared independently by Jonathan Novoa.
19/01/2016

Chemical prevention of seasonal malaria (CPS) has been implemented in Niger since 2013, pursuant to the recommendations of the World Health Organization (WHO) and the national anti-malaria policy. It consists of a mass campaign involving the administration of curative doses of sulphadoxine-pyrimethamine (SP) and amodiaquine (AQ) to children between the ages of 3 and 59 months for three days, at 28-day intervals, between July and November.

Alena Koscalova
29/09/2015

The Ebola Workshop in Dakar, held over 3 days in June 2015, brought together experienced Ebola field people and HQ staff from diverse specialties and all MSF sections to reflect on lessons learned so far and make recommendations in the areas of outreach response, patient care, human resources and strategy. Participants placed a high value on intersectional approaches within MSF, and on strong engagement with key external organizations in preparing flexible, adapted, more effective responses to future outbreaks of Ebola or other mass epidemics. 

By Patricia Kahn, with input from Sebastian Stein. Based on summaries by Amanda Tiffany, Roberta Petrucci, Ruth Kauffman and Sebastian Stein.
01/07/2015

La chimio-prévention du paludisme saisonnier (CPS) a été mise en œuvre au Niger depuis 2013, conformément aux recommandations de l'Organisation mondiale de la Santé (OMS) et à la politique nationale de lutte contre le paludisme. Elle se déroule sous la forme d’une campagne de masse qui consiste en l’administration de doses curatives de sulphadoxine-pyriméthamine (SP) et d'amodiaquine (AQ) durant trois jours, à 28 jours d’intervalle entre juillet et novembre, aux enfants de 3 à 59 mois.

by Alena Koscalova
01/02/2015

Pages